Dataset Information
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Ontology highlight
ABSTRACT:
SUBMITTER: Baumert BG
PROVIDER: S-EPMC5124485 | biostudies-literature | 2016 Nov
REPOSITORIES: biostudies-literature
